Even if FDA is amenable to allowing more manufacturer communication about off-label uses, FDA may have trouble finding the money to police it.
During the second day of FDA's public hearing on the subject, one stakeholder was concerned that the growth in off-label...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?